Primary surgery with or without postoperative radiotherapy in early stage squamous cell carcinoma in the anal canal and anal margin

References

• Glynne-Jones R, Nilsson PJ, Aschele C, et al. Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(Suppl 3):iii10–iii20.
   PubMed Web of Science ®Google Scholar
• Bjorge T, Engeland A, Luostarinen T, et al. Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. Br J Cancer. 2002;87:61–64.
   PubMed Web of Science ®Google Scholar
• Ajani JA, Winter KA, Gunderson LL, et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA. 2008;299:1914–1921.
   PubMed Web of Science ®Google Scholar
• Leon O, Guren M, Hagberg O, et al. Anal carcinoma – survival and recurrence in a large cohort of patients treated according to Nordic guidelines. Radiother Oncol. 2014;113:352–358.
   PubMed Web of Science ®Google Scholar
• Bentzen AG, Balteskard L, Wanderas EH, et al. Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors. Acta Oncol. 2013;52:736–744.
   PubMed Web of Science ®Google Scholar
• Schraut WH, Wang CH, Dawson PJ, et al. Depth of invasion, location, and size of cancer of the anus dictate operative treatment. Cancer. 1983;51:1291–1296.
   PubMed Web of Science ®Google Scholar
• Boman BM, Moertel CG, O’Connell MJ, et al. Carcinoma of the anal canal. A clinical and pathologic study of 188 cases. Cancer. 1984;54:114–125.
   PubMed Web of Science ®Google Scholar
• Longo WE, Vernava AM III, Wade TP, et al. Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy. Ann Surg. 1994;220:40–49.
   PubMed Web of Science ®Google Scholar
• Greenall MJ, Quan SH, Stearns MW, et al. Epidermoid cancer of the anal margin. Pathologic features, treatment, and clinical results. Am J Surg. 1985;149:95–101.
   PubMed Web of Science ®Google Scholar
• Goldman S, Glimelius B, Glas U, et al. Management of anal epidermoid carcinoma – an evaluation of treatment results in two population-based series. Int J Colorect Dis. 1989;4:234–243.
   PubMed Web of Science ®Google Scholar
• Nigro ND, Vaitkevicius VK, Considine B Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum. 1974;17:354–356.
   PubMed Web of Science ®Google Scholar
• Peiffert D, Tournier-Rangeard L, Gerard JP, et al. Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial. J Clin Oncol. 2012;30:1941–1948.
   PubMed Web of Science ®Google Scholar
• James RD, Glynne-Jones R, Meadows HM, et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial. Lancet Oncol. 2013;14:516–524.
   PubMed Web of Science ®Google Scholar
• Chai CY, Cao HT, Awad S, et al. Management of stage I squamous cell carcinoma of the anal canal. JAMA Surg. 2017 [cited 2017 Oct 18]. DOI:https://doi.org/10.1001/jamasurg.2017.3151
   Web of Science ®Google Scholar
• Ortholan C, Ramaioli A, Peiffert D, et al. Anal canal carcinoma: early-stage tumors < or =10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62:479–485.
   PubMed Web of Science ®Google Scholar
• Hatfield P, Cooper R, Sebag-Montefiore D. Involved-field, low-dose chemoradiotherapy for early-stage anal carcinoma. Int J Radiat Oncol Biol Phys. 2008;70:419–424.
   PubMed Web of Science ®Google Scholar
• Hu K, Minsky BD, Cohen AM, et al. 30 Gy may be an adequate dose in patients with anal cancer treated with excisional biopsy followed by combined-modality therapy. J Surg Oncol. 1999; 70:71–77.
   PubMed Web of Science ®Google Scholar
• Bentzen AG, Guren MG, Vonen B, et al. Faecal incontinence after chemoradiotherapy in anal cancer survivors: long-term results of a national cohort. Radiother Oncol. 2013;108:55–60.
   PubMed Web of Science ®Google Scholar